ReP USP - Resultado da busca

Artigo de periodico
Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers: a pilot, proof-of-concept, randomized controlled trial (2021)
Rocha, Juliana Mendes; Rossi, Giordano Novak ; Osório, Flávia de Lima ; Bouso, José Carlos ; Silveira, Gabriela de Oliveira ; Yonamine, Maurício ; Campos, Alline Cristina de ; Bertozi, Giuliana; Cecílio, Hallak Jaime E; Santos, Rafael Guimarães dos
Source: Journal of Clinical Psychopharmacology. Unidades: FMRP, FCF
Subjects: PSICOFARMACOLOGIA, COGNIÇÃO SOCIAL, ALUCINOGÊNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Juliana Mendes et al. Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers: a pilot, proof-of-concept, randomized controlled trial. Journal of Clinical Psychopharmacology, v. 41, n. 3, p. 267-274, 2021Tradução . . Disponível em: https://doi.org/10.1097/JCP.0000000000001396. Acesso em: 16 set. 2024.
APA
Rocha, J. M., Rossi, G. N., Osório, F. de L., Bouso, J. C., Silveira, G. de O., Yonamine, M., et al. (2021). Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers: a pilot, proof-of-concept, randomized controlled trial. Journal of Clinical Psychopharmacology, 41( 3), 267-274. doi:10.1097/JCP.0000000000001396
NLM
Rocha JM, Rossi GN, Osório F de L, Bouso JC, Silveira G de O, Yonamine M, Campos AC de, Bertozi G, Cecílio HJE, Santos RG dos. Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers: a pilot, proof-of-concept, randomized controlled trial [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 267-274.[citado 2024 set. 16 ] Available from: https://doi.org/10.1097/JCP.0000000000001396
Vancouver
Rocha JM, Rossi GN, Osório F de L, Bouso JC, Silveira G de O, Yonamine M, Campos AC de, Bertozi G, Cecílio HJE, Santos RG dos. Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers: a pilot, proof-of-concept, randomized controlled trial [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 267-274.[citado 2024 set. 16 ] Available from: https://doi.org/10.1097/JCP.0000000000001396
Artigo de periodico
Ketamine effects on anxiety and fear-related behaviors: current literature evidence and new findings (2020)
Silote, Gabriela Pandini; Oliveira, Sabrina F. S. de; Ribeiro, Deidiane Elisa; Machado, Mayara S.; Andreatini, Roberto; Joca, Sâmia Regiane Lourenço ; Beijamini, Vanessa
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidade: FCFRP
Subjects: ANSIEDADE, MEDO, COMPORTAMENTO, PSICOFARMACOLOGIA, PÂNICO, MODELOS ANIMAIS, ANTAGONISTAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILOTE, Gabriela Pandini et al. Ketamine effects on anxiety and fear-related behaviors: current literature evidence and new findings. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 100, p. 1-14, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2020.109878. Acesso em: 16 set. 2024.
APA
Silote, G. P., Oliveira, S. F. S. de, Ribeiro, D. E., Machado, M. S., Andreatini, R., Joca, S. R. L., & Beijamini, V. (2020). Ketamine effects on anxiety and fear-related behaviors: current literature evidence and new findings. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 100, 1-14. doi:10.1016/j.pnpbp.2020.109878
NLM
Silote GP, Oliveira SFS de, Ribeiro DE, Machado MS, Andreatini R, Joca SRL, Beijamini V. Ketamine effects on anxiety and fear-related behaviors: current literature evidence and new findings [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2020 ; 100 1-14.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.pnpbp.2020.109878
Vancouver
Silote GP, Oliveira SFS de, Ribeiro DE, Machado MS, Andreatini R, Joca SRL, Beijamini V. Ketamine effects on anxiety and fear-related behaviors: current literature evidence and new findings [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2020 ; 100 1-14.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.pnpbp.2020.109878
Artigo de periodico
Therapeutic treatment with Modafinil decreases the severity of experimental autoimmune encephalomyelitis in mice (2019)
Brandão, Wesley Nogueira ; Andersen, Monica Levy ; Palermo-Neto, João ; Peron, Jean Pierre Schatzmann ; Zager, Adriano
Source: International Immunopharmacology. Unidades: FMVZ, ICB
Subjects: ENCEFALOMIELITE ANIMAL, PSICOFARMACOLOGIA, FÁRMACOS PSICOTRÓPICOS, INFLAMAÇÃO, RECEPTORES DE DOPAMINA, IMUNIDADE, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANDÃO, Wesley Nogueira et al. Therapeutic treatment with Modafinil decreases the severity of experimental autoimmune encephalomyelitis in mice. International Immunopharmacology, v. 75, p. 1-7, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.intimp.2019.105809. Acesso em: 16 set. 2024.
APA
Brandão, W. N., Andersen, M. L., Palermo-Neto, J., Peron, J. P. S., & Zager, A. (2019). Therapeutic treatment with Modafinil decreases the severity of experimental autoimmune encephalomyelitis in mice. International Immunopharmacology, 75, 1-7. doi:10.1016/j.intimp.2019.105809
NLM
Brandão WN, Andersen ML, Palermo-Neto J, Peron JPS, Zager A. Therapeutic treatment with Modafinil decreases the severity of experimental autoimmune encephalomyelitis in mice [Internet]. International Immunopharmacology. 2019 ; 75 1-7.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.intimp.2019.105809
Vancouver
Brandão WN, Andersen ML, Palermo-Neto J, Peron JPS, Zager A. Therapeutic treatment with Modafinil decreases the severity of experimental autoimmune encephalomyelitis in mice [Internet]. International Immunopharmacology. 2019 ; 75 1-7.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.intimp.2019.105809
Artigo de periodico
Cannabidiol attenuates aggressive behavior induced by social isolation in mice: involvement of 5-HT1A and CB1 receptors (2019)
Santos, Alice Hartmann dos; Lisboa, Sabrina Francesca de Souza ; Sonego, Andreza Buzolin; Coutinho, Débora; Gomes, Felipe Villela ; Guimarães, Francisco Silveira
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FCFRP, FMRP
Subjects: CANABINOIDES, AGRESSIVIDADE, COMPORTAMENTO ANIMAL, PSICOFARMACOLOGIA, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Alice Hartmann dos et al. Cannabidiol attenuates aggressive behavior induced by social isolation in mice: involvement of 5-HT1A and CB1 receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 94, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2019.109637. Acesso em: 16 set. 2024.
APA
Santos, A. H. dos, Lisboa, S. F. de S., Sonego, A. B., Coutinho, D., Gomes, F. V., & Guimarães, F. S. (2019). Cannabidiol attenuates aggressive behavior induced by social isolation in mice: involvement of 5-HT1A and CB1 receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 94. doi:10.1016/j.pnpbp.2019.109637
NLM
Santos AH dos, Lisboa SF de S, Sonego AB, Coutinho D, Gomes FV, Guimarães FS. Cannabidiol attenuates aggressive behavior induced by social isolation in mice: involvement of 5-HT1A and CB1 receptors [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019 ; 94[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.pnpbp.2019.109637
Vancouver
Santos AH dos, Lisboa SF de S, Sonego AB, Coutinho D, Gomes FV, Guimarães FS. Cannabidiol attenuates aggressive behavior induced by social isolation in mice: involvement of 5-HT1A and CB1 receptors [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019 ; 94[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.pnpbp.2019.109637
Artigo de periodico
Treatment of anxiety disorders in clinical practice: a critical overview of recent systematic evidence (2019)
Mangolini, Vitor Iglesias; Andrade, Laura Helena; Lotufo-Neto, Francisco ; Wang, Yuan-Pang
Source: Clinics. Unidade: FM
Subjects: TRANSTORNOS DA ANSIEDADE, MEDICINA BASEADA EM EVIDÊNCIAS, PSICOTERAPIA, PSICOFARMACOLOGIA, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANGOLINI, Vitor Iglesias et al. Treatment of anxiety disorders in clinical practice: a critical overview of recent systematic evidence. Clinics, v. 74, 2019Tradução . . Disponível em: https://doi.org/10.6061/clinics/2019/e1316. Acesso em: 16 set. 2024.
APA
Mangolini, V. I., Andrade, L. H., Lotufo-Neto, F., & Wang, Y. -P. (2019). Treatment of anxiety disorders in clinical practice: a critical overview of recent systematic evidence. Clinics, 74. doi:10.6061/clinics/2019/e1316
NLM
Mangolini VI, Andrade LH, Lotufo-Neto F, Wang Y-P. Treatment of anxiety disorders in clinical practice: a critical overview of recent systematic evidence [Internet]. Clinics. 2019 ; 74[citado 2024 set. 16 ] Available from: https://doi.org/10.6061/clinics/2019/e1316
Vancouver
Mangolini VI, Andrade LH, Lotufo-Neto F, Wang Y-P. Treatment of anxiety disorders in clinical practice: a critical overview of recent systematic evidence [Internet]. Clinics. 2019 ; 74[citado 2024 set. 16 ] Available from: https://doi.org/10.6061/clinics/2019/e1316
Artigo de periodico
Psicofarmacoterapia para o clínico geral (2017)
Baes, Cristiane Von Werne; Juruena, Mário Francisco Pereira
Source: Medicina (Ribeirão Preto. Online). Unidade: FMRP
Subjects: PSICOFARMACOLOGIA, FARMACOTERAPIA, EDUCAÇÃO MÉDICA, TRANSTORNOS MENTAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAES, Cristiane Von Werne e JURUENA, Mário Francisco Pereira. Psicofarmacoterapia para o clínico geral. Medicina (Ribeirão Preto. Online), v. 50, p. 22-36, 2017Tradução . . Disponível em: https://doi.org/10.11606/issn.2176-7262.v50isupl1.p22-36. Acesso em: 16 set. 2024.
APA
Baes, C. V. W., & Juruena, M. F. P. (2017). Psicofarmacoterapia para o clínico geral. Medicina (Ribeirão Preto. Online), 50, 22-36. doi:10.11606/issn.2176-7262.v50isupl1.p22-36
NLM
Baes CVW, Juruena MFP. Psicofarmacoterapia para o clínico geral [Internet]. Medicina (Ribeirão Preto. Online). 2017 ; 50 22-36.[citado 2024 set. 16 ] Available from: https://doi.org/10.11606/issn.2176-7262.v50isupl1.p22-36
Vancouver
Baes CVW, Juruena MFP. Psicofarmacoterapia para o clínico geral [Internet]. Medicina (Ribeirão Preto. Online). 2017 ; 50 22-36.[citado 2024 set. 16 ] Available from: https://doi.org/10.11606/issn.2176-7262.v50isupl1.p22-36
Artigo de periodico
The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder (2014)
Diniz, Juliana B.; Costa, Daniel L. C.; Cassab, Raony C. C.; Pereira, Carlos A. B.; Miguel, Euripedes C.; Shavitt, Roseli G.
Source: Journal of Psychopharmacology. Unidades: FM, IME
Subjects: ANOREXIA, COMORBIDADE, TRANSTORNO OBSESSIVO-COMPULSIVO, PSICOFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Juliana B. et al. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder. Journal of Psychopharmacology, n. 6, p. 603-611, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.tiv.2014.02.011. Acesso em: 16 set. 2024.
APA
Diniz, J. B., Costa, D. L. C., Cassab, R. C. C., Pereira, C. A. B., Miguel, E. C., & Shavitt, R. G. (2014). The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder. Journal of Psychopharmacology, ( 6), 603-611. doi:10.1016/j.tiv.2014.02.011
NLM
Diniz JB, Costa DLC, Cassab RCC, Pereira CAB, Miguel EC, Shavitt RG. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder [Internet]. Journal of Psychopharmacology. 2014 ;( 6): 603-611.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.tiv.2014.02.011
Vancouver
Diniz JB, Costa DLC, Cassab RCC, Pereira CAB, Miguel EC, Shavitt RG. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder [Internet]. Journal of Psychopharmacology. 2014 ;( 6): 603-611.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.tiv.2014.02.011
Artigo de periodico
Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channels (2014)
Aguiar, D. C.; Moreira, F. A.; Terzian, A. L.; Fogaça, Manoela V.; Lisboa, S. F.; Wotjak, C. T.; Guimarães, Francisco Silveira
Source: Neuroscience & Biobehavioral Reviews. Unidade: FMRP
Subjects: ANSIEDADE, RECEPTORES, MEDO, PSICOFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, D. C. et al. Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channels. Neuroscience & Biobehavioral Reviews, v. 46, p. 418–428, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.neubiorev.2014.03.026. Acesso em: 16 set. 2024.
APA
Aguiar, D. C., Moreira, F. A., Terzian, A. L., Fogaça, M. V., Lisboa, S. F., Wotjak, C. T., & Guimarães, F. S. (2014). Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channels. Neuroscience & Biobehavioral Reviews, 46, 418–428. doi:10.1016/j.neubiorev.2014.03.026
NLM
Aguiar DC, Moreira FA, Terzian AL, Fogaça MV, Lisboa SF, Wotjak CT, Guimarães FS. Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channels [Internet]. Neuroscience & Biobehavioral Reviews. 2014 ; 46 418–428.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.neubiorev.2014.03.026
Vancouver
Aguiar DC, Moreira FA, Terzian AL, Fogaça MV, Lisboa SF, Wotjak CT, Guimarães FS. Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channels [Internet]. Neuroscience & Biobehavioral Reviews. 2014 ; 46 418–428.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.neubiorev.2014.03.026
Artigo de periodico
Medial prefrontal cortex transient receptor potential vanilloid type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats (2014)
Terzian, Ana Luisa B.; Reis, Daniel Gustavo dos; Guimarães, Francisco Silveira; Corrêa, Fernando Morgan de Aguiar; Resstel, Leonardo Barbosa Moraes
Source: Psychopharmacology. Unidade: FMRP
Subjects: RECEPTORES, CANAIS IÔNICOS, MEDO, CÓRTEX PRÉ-FRONTAL, SISTEMA CARDIOVASCULAR, PSICOFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TERZIAN, Ana Luisa B. et al. Medial prefrontal cortex transient receptor potential vanilloid type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats. Psychopharmacology, v. 231, n. 1, p. 149-157, 2014Tradução . . Disponível em: https://doi.org/10.1007/s00213-013-3211-9. Acesso em: 16 set. 2024.
APA
Terzian, A. L. B., Reis, D. G. dos, Guimarães, F. S., Corrêa, F. M. de A., & Resstel, L. B. M. (2014). Medial prefrontal cortex transient receptor potential vanilloid type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats. Psychopharmacology, 231( 1), 149-157. doi:10.1007/s00213-013-3211-9
NLM
Terzian ALB, Reis DG dos, Guimarães FS, Corrêa FM de A, Resstel LBM. Medial prefrontal cortex transient receptor potential vanilloid type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats [Internet]. Psychopharmacology. 2014 ; 231( 1): 149-157.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s00213-013-3211-9
Vancouver
Terzian ALB, Reis DG dos, Guimarães FS, Corrêa FM de A, Resstel LBM. Medial prefrontal cortex transient receptor potential vanilloid type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats [Internet]. Psychopharmacology. 2014 ; 231( 1): 149-157.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s00213-013-3211-9
Artigo de periodico
Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats (2013)
Fogaça, Manoela V.; Gomes, Felipe V.; Moreira, Fabrício A.; Guimarães, Francisco Silveira; Aguiar, Daniele Cristina
Source: Psychopharmacology. Unidade: FMRP
Subjects: GLUTAMATOS, ANSIEDADE, PSICOFARMACOLOGIA, COMPORTAMENTO DEFENSIVO ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOGAÇA, Manoela V. et al. Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats. Psychopharmacology, v. 226, n. 3, p. 579-587, 2013Tradução . . Disponível em: https://doi.org/10.1007/s00213-012-2927-2. Acesso em: 16 set. 2024.
APA
Fogaça, M. V., Gomes, F. V., Moreira, F. A., Guimarães, F. S., & Aguiar, D. C. (2013). Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats. Psychopharmacology, 226( 3), 579-587. doi:10.1007/s00213-012-2927-2
NLM
Fogaça MV, Gomes FV, Moreira FA, Guimarães FS, Aguiar DC. Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats [Internet]. Psychopharmacology. 2013 ; 226( 3): 579-587.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s00213-012-2927-2
Vancouver
Fogaça MV, Gomes FV, Moreira FA, Guimarães FS, Aguiar DC. Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats [Internet]. Psychopharmacology. 2013 ; 226( 3): 579-587.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s00213-012-2927-2
Artigo de periodico
Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-H'T IND.1A' receptor activation in mice (2013)
Gomes, Felipe V.; Del Bel, Elaine Aparecida; Guimarães, Francisco Silveira
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FORP, FMRP
Subjects: RECEPTORES DE SEROTONINA, CANNABIS, CATALEPSIA, PSICOFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe V. e DEL BEL, Elaine Aparecida e GUIMARÃES, Francisco Silveira. Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-H'T IND.1A' receptor activation in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 46, p. 43-47, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2013.06.005. Acesso em: 16 set. 2024.
APA
Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2013). Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-H'T IND.1A' receptor activation in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 46, 43-47. doi:10.1016/j.pnpbp.2013.06.005
NLM
Gomes FV, Del Bel EA, Guimarães FS. Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-H'T IND.1A' receptor activation in mice [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013 ; 46 43-47.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.pnpbp.2013.06.005
Vancouver
Gomes FV, Del Bel EA, Guimarães FS. Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-H'T IND.1A' receptor activation in mice [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013 ; 46 43-47.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.pnpbp.2013.06.005
Artigo de periodico
Tratamentos farmacológicos para o transtorno de ansiedade social: existem novos parâmetros na atualidade ? (2011)
Santos, Larissa Forni dos; Osório, Flávia de Lima; Loureiro, Sonia Regina; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza
Source: Revista de Psiquiatria Clínica. Unidade: FMRP
Subjects: PSICOFARMACOLOGIA, FÁRMACOS PSICOTRÓPICOS, FOBIA SOCIAL, TRANSTORNOS DA ANSIEDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Larissa Forni dos et al. Tratamentos farmacológicos para o transtorno de ansiedade social: existem novos parâmetros na atualidade ?. Revista de Psiquiatria Clínica, v. 38, n. 6, p. 238-246, 2011Tradução . . Disponível em: https://doi.org/10.1590/s0101-60832011000600005. Acesso em: 16 set. 2024.
APA
Santos, L. F. dos, Osório, F. de L., Loureiro, S. R., Hallak, J. E. C., & Crippa, J. A. de S. (2011). Tratamentos farmacológicos para o transtorno de ansiedade social: existem novos parâmetros na atualidade ? Revista de Psiquiatria Clínica, 38( 6), 238-246. doi:10.1590/s0101-60832011000600005
NLM
Santos LF dos, Osório F de L, Loureiro SR, Hallak JEC, Crippa JA de S. Tratamentos farmacológicos para o transtorno de ansiedade social: existem novos parâmetros na atualidade ? [Internet]. Revista de Psiquiatria Clínica. 2011 ; 38( 6): 238-246.[citado 2024 set. 16 ] Available from: https://doi.org/10.1590/s0101-60832011000600005
Vancouver
Santos LF dos, Osório F de L, Loureiro SR, Hallak JEC, Crippa JA de S. Tratamentos farmacológicos para o transtorno de ansiedade social: existem novos parâmetros na atualidade ? [Internet]. Revista de Psiquiatria Clínica. 2011 ; 38( 6): 238-246.[citado 2024 set. 16 ] Available from: https://doi.org/10.1590/s0101-60832011000600005
Artigo de periodico
The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects (2011)
Hallak, Jaime Eduardo Cecílio; Dursun, Serdar M.; Bosi, Daniel C.; Macedo, Ligia Ribeiro Horta de; Machado-de-Sousa, João Paulo; Abrão, João; Crippa, José Alexandre de Souza; McGuire, Phillip; Krystal, John H.; Baker, Glen B.; Zuardi, Antonio Waldo
Source: Progress in Neuro-Psychopharmacology & Biological Psychiatry. Unidade: FMRP
Subjects: TRANSTORNOS PSICÓTICOS, PSICOFARMACOLOGIA, CANNABIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HALLAK, Jaime Eduardo Cecílio et al. The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry, v. 35, n. 1, p. 198-202, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2010.11.002. Acesso em: 16 set. 2024.
APA
Hallak, J. E. C., Dursun, S. M., Bosi, D. C., Macedo, L. R. H. de, Machado-de-Sousa, J. P., Abrão, J., et al. (2011). The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35( 1), 198-202. doi:10.1016/j.pnpbp.2010.11.002
NLM
Hallak JEC, Dursun SM, Bosi DC, Macedo LRH de, Machado-de-Sousa JP, Abrão J, Crippa JA de S, McGuire P, Krystal JH, Baker GB, Zuardi AW. The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects [Internet]. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2011 ; 35( 1): 198-202.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.pnpbp.2010.11.002
Vancouver
Hallak JEC, Dursun SM, Bosi DC, Macedo LRH de, Machado-de-Sousa JP, Abrão J, Crippa JA de S, McGuire P, Krystal JH, Baker GB, Zuardi AW. The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects [Internet]. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2011 ; 35( 1): 198-202.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.pnpbp.2010.11.002
Artigo de periodico
Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze (2007)
Zanoveli, Janaína Menezes; Nogueira, Regina Lúcia; Zangrossi Júnior, Hélio
Source: Neuropharmacology. Unidade: FMRP
Subjects: PSICOFARMACOLOGIA, PÂNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANOVELI, Janaína Menezes e NOGUEIRA, Regina Lúcia e ZANGROSSI JÚNIOR, Hélio. Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze. Neuropharmacology, v. 52, n. 4, p. 1188-1195, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2007.01.001. Acesso em: 16 set. 2024.
APA
Zanoveli, J. M., Nogueira, R. L., & Zangrossi Júnior, H. (2007). Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze. Neuropharmacology, 52( 4), 1188-1195. doi:10.1016/j.neuropharm.2007.01.001
NLM
Zanoveli JM, Nogueira RL, Zangrossi Júnior H. Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze [Internet]. Neuropharmacology. 2007 ; 52( 4): 1188-1195.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.neuropharm.2007.01.001
Vancouver
Zanoveli JM, Nogueira RL, Zangrossi Júnior H. Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze [Internet]. Neuropharmacology. 2007 ; 52( 4): 1188-1195.[citado 2024 set. 16 ] Available from: https://doi.org/10.1016/j.neuropharm.2007.01.001
Artigo de periodico
Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects (2006)
Joca, Sâmia Regiane Lourenço; Guimarães, Francisco Silveira
Source: Psychopharmacology. Unidade: FMRP
Subjects: PSICOFARMACOLOGIA, ÓXIDO NÍTRICO, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOCA, Sâmia Regiane Lourenço e GUIMARÃES, Francisco Silveira. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology, v. 185, p. 298-305, 2006Tradução . . Disponível em: https://doi.org/10.1007/s00213-006-0326-2. Acesso em: 16 set. 2024.
APA
Joca, S. R. L., & Guimarães, F. S. (2006). Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology, 185, 298-305. doi:10.1007/s00213-006-0326-2
NLM
Joca SRL, Guimarães FS. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects [Internet]. Psychopharmacology. 2006 ; 185 298-305.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s00213-006-0326-2
Vancouver
Joca SRL, Guimarães FS. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects [Internet]. Psychopharmacology. 2006 ; 185 298-305.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s00213-006-0326-2
Artigo de periodico
Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats (2006)
Forestiero, Daniel; Manfrim, Carlos Mora; Guimarães, Francisco Silveira; Oliveira, Rúbia Maria Weffort de
Source: Psychopharmacology. Unidade: FMRP
Subjects: PSICOFARMACOLOGIA, ÓXIDO NÍTRICO, ANSIEDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORESTIERO, Daniel et al. Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats. Psychopharmacology, v. 184, p. 166-172, 2006Tradução . . Disponível em: https://doi.org/10.1007/s00213-005-0270-6. Acesso em: 16 set. 2024.
APA
Forestiero, D., Manfrim, C. M., Guimarães, F. S., & Oliveira, R. M. W. de. (2006). Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats. Psychopharmacology, 184, 166-172. doi:10.1007/s00213-005-0270-6
NLM
Forestiero D, Manfrim CM, Guimarães FS, Oliveira RMW de. Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats [Internet]. Psychopharmacology. 2006 ; 184 166-172.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s00213-005-0270-6
Vancouver
Forestiero D, Manfrim CM, Guimarães FS, Oliveira RMW de. Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats [Internet]. Psychopharmacology. 2006 ; 184 166-172.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s00213-005-0270-6
Artigo de periodico
Neuronal effects of acute citalopram detected bu pharmacoMRI (2005)
McKie, S.; Del-Ben, C.; Elliott, R.; Williams, S.; del Vai, N.; Anderson, I.; Deakin, J. F. W.
Source: Psychopharmacology. Unidade: FMRP
Assunto: PSICOFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MCKIE, S. et al. Neuronal effects of acute citalopram detected bu pharmacoMRI. Psychopharmacology, v. 180, p. 680-686, 2005Tradução . . Disponível em: https://doi.org/10.1007/s00213-005-2270-y. Acesso em: 16 set. 2024.
APA
McKie, S., Del-Ben, C., Elliott, R., Williams, S., del Vai, N., Anderson, I., & Deakin, J. F. W. (2005). Neuronal effects of acute citalopram detected bu pharmacoMRI. Psychopharmacology, 180, 680-686. doi:10.1007/s00213-005-2270-y
NLM
McKie S, Del-Ben C, Elliott R, Williams S, del Vai N, Anderson I, Deakin JFW. Neuronal effects of acute citalopram detected bu pharmacoMRI [Internet]. Psychopharmacology. 2005 ; 180 680-686.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s00213-005-2270-y
Vancouver
McKie S, Del-Ben C, Elliott R, Williams S, del Vai N, Anderson I, Deakin JFW. Neuronal effects of acute citalopram detected bu pharmacoMRI [Internet]. Psychopharmacology. 2005 ; 180 680-686.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s00213-005-2270-y
Artigo de periodico
'5-HT IND.1A' and '5-HT IND.2A' receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus (2005)
Pobbe, Roger L. H.; Zangrossi Júnior, Hélio
Source: Psychopharmacology. Unidade: FMRP
Assunto: PSICOFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POBBE, Roger L. H. e ZANGROSSI JÚNIOR, Hélio. '5-HT IND.1A' and '5-HT IND.2A' receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus. Psychopharmacology, v. 183, p. 314-321, 2005Tradução . . Disponível em: https://doi.org/10.1007/s00213-005-0196-z. Acesso em: 16 set. 2024.
APA
Pobbe, R. L. H., & Zangrossi Júnior, H. (2005). '5-HT IND.1A' and '5-HT IND.2A' receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus. Psychopharmacology, 183, 314-321. doi:10.1007/s00213-005-0196-z
NLM
Pobbe RLH, Zangrossi Júnior H. '5-HT IND.1A' and '5-HT IND.2A' receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus [Internet]. Psychopharmacology. 2005 ; 183 314-321.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s00213-005-0196-z
Vancouver
Pobbe RLH, Zangrossi Júnior H. '5-HT IND.1A' and '5-HT IND.2A' receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus [Internet]. Psychopharmacology. 2005 ; 183 314-321.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s00213-005-0196-z
Artigo de periodico
Effect of the blockade of 'mü IND 1'-opioid and '5HT IND 2A'-serotonergic/álfa IND 1'-noradrenergic receptors on sweet-substance -induced analgesia (2005)
Rebouças, E. C. C.; Segato, E. N.; Kishi, R.; Freitas, R. L.; Savoldi, Marcela; Morato, S.; Coimbra, Norberto Cysne
Source: Psychopharmacology. Unidades: FCFRP, FMRP
Subjects: ANALGESIA, PSICOFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REBOUÇAS, E. C. C. et al. Effect of the blockade of 'mü IND 1'-opioid and '5HT IND 2A'-serotonergic/álfa IND 1'-noradrenergic receptors on sweet-substance -induced analgesia. Psychopharmacology, v. 179, p. 349-355, 2005Tradução . . Acesso em: 16 set. 2024.
APA
Rebouças, E. C. C., Segato, E. N., Kishi, R., Freitas, R. L., Savoldi, M., Morato, S., & Coimbra, N. C. (2005). Effect of the blockade of 'mü IND 1'-opioid and '5HT IND 2A'-serotonergic/álfa IND 1'-noradrenergic receptors on sweet-substance -induced analgesia. Psychopharmacology, 179, 349-355.
NLM
Rebouças ECC, Segato EN, Kishi R, Freitas RL, Savoldi M, Morato S, Coimbra NC. Effect of the blockade of 'mü IND 1'-opioid and '5HT IND 2A'-serotonergic/álfa IND 1'-noradrenergic receptors on sweet-substance -induced analgesia. Psychopharmacology. 2005 ; 179 349-355.[citado 2024 set. 16 ]
Vancouver
Rebouças ECC, Segato EN, Kishi R, Freitas RL, Savoldi M, Morato S, Coimbra NC. Effect of the blockade of 'mü IND 1'-opioid and '5HT IND 2A'-serotonergic/álfa IND 1'-noradrenergic receptors on sweet-substance -induced analgesia. Psychopharmacology. 2005 ; 179 349-355.[citado 2024 set. 16 ]
Artigo de periodico
The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests (2005)
Bueno, C. H.; Zangrossi Júnior, Hélio; Viana, M B
Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: PSICOFARMACOLOGIA, ANSIEDADE, PÂNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, C. H. e ZANGROSSI JÚNIOR, Hélio e VIANA, M B. The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests. Brazilian Journal of Medical and Biological Research, v. 38, n. 11, p. 1691-1696, 2005Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2005001100019. Acesso em: 16 set. 2024.
APA
Bueno, C. H., Zangrossi Júnior, H., & Viana, M. B. (2005). The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests. Brazilian Journal of Medical and Biological Research, 38( 11), 1691-1696. doi:10.1590/s0100-879x2005001100019
NLM
Bueno CH, Zangrossi Júnior H, Viana MB. The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests [Internet]. Brazilian Journal of Medical and Biological Research. 2005 ; 38( 11): 1691-1696.[citado 2024 set. 16 ] Available from: https://doi.org/10.1590/s0100-879x2005001100019
Vancouver
Bueno CH, Zangrossi Júnior H, Viana MB. The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests [Internet]. Brazilian Journal of Medical and Biological Research. 2005 ; 38( 11): 1691-1696.[citado 2024 set. 16 ] Available from: https://doi.org/10.1590/s0100-879x2005001100019

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation